SHH and esophageal squamous cell carcinoma: Furthermore, continuous cisplatin treatment increased Shh signaling as shown by increased GLI1 nuclear translocation and PTCH1 levels, which in turn upregulate the expression of ABCB1 to reduce cisplatin enrichment in the ESCC ALDH+ TE-1 cell line.